Hypersecretion of calcitonin
- E07.0 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
- The 2025 edition of ICD-10-CM E07.0 became effective on October 1, 2024.
- This is the American ICD-10-CM version of E07.0 – other international versions of ICD-10 E07.0 may differ.
Applicable To
- C-cell hyperplasia of thyroid
- Hypersecretion of thyrocalcitonin
The following code(s) above E07.0 contain annotation back-references
that may be applicable to E07.0:
- E00-E89 Endocrine, nutritional and metabolic diseases
ICD-10-CM E07.0 is grouped within Diagnostic Related Group(s) (MS-DRG v42.0):
- 643 Endocrine disorders with mcc
- 644 Endocrine disorders with cc
- 645 Endocrine disorders without cc/mcc
Convert E07.0 to ICD-9-CMCode History
- 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
- 2017 (effective 10/1/2016): No change
- 2018 (effective 10/1/2017): No change
- 2019 (effective 10/1/2018): No change
- 2020 (effective 10/1/2019): No change
- 2021 (effective 10/1/2020): No change
- 2022 (effective 10/1/2021): No change
- 2023 (effective 10/1/2022): No change
- 2024 (effective 10/1/2023): No change
- 2025 (effective 10/1/2024): No change
Diagnosis Index entries containing back-references to E07.0:
- Disorder (of) – see also Disease
- secretion, thyrocalcitonin E07.0
- thyrocalcitonin hypersecretion E07.0
- Hyperplasia, hyperplastic
- C-cell, thyroid E07.0
- Hypersecretion
- calcitonin E07.0
- thyrocalcitonin E07.0